TL;DR GLP-1 patches (including Kind Patches, Gentle Patches, Patched GLP-1, Oceaura, and Ledisa) are over-the-counter adhesive skin patches marketed for weight management
The role of emerging therapies The diabetes and obesity treatment landscape continues to evolve rapidly
Clinical trial dosage results summary The dosage charts above are not arbitrary
Under clinical investigation for obesity and metabolic dysfunction
Authoritative Sources New England Journal of Medicine phase 2 trial: peer-reviewed study data on retatrutide in adults with obesity
Key distinctions in the evidence: Tesamorelin: licensed in the US, narrowly indicated, established in HIV-related lipodystrophy, with effects that reverse on stopping treatment Retatrutide: investigational, broader metabolic potential, not yet approved anywhere globally Patients and clinicians should interpret early-phase data for retatrutide with appropriate caution